Profil
Carol Waldo worked as the Vice President of Regulatory Affairs at Cubist Pharmaceuticals LLC.
She then served as the Head of Regulatory Affairs at Spero Therapeutics, Inc. from 2016 to 2019.
Ms. Waldo's most recent position was as the Senior VP of Regulatory Affairs & Quality Assurance at Cidara Therapeutics, Inc. from 2021 to 2023.
She completed her undergraduate degree at North Central College.
Ehemalige bekannte Positionen von Carol Waldo
| Unternehmen | Position | Ende |
|---|---|---|
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.08.2023 |
| SPERO THERAPEUTICS, INC. | General Counsel | 01.02.2019 |
| CUBIST PHARMACEUTICALS INC | General Counsel | - |
Ausbildung von Carol Waldo
| North Central College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
